The Retina Specialist's Role in Systemic Diabetes Control
Robert L. Avery, MD, Associate Medical Editor and Allen C. Ho, MD, Chief Medical Editor
Additional Perspectives on Protocol T
Some aspects of the trial may warrant closer scrutiny before clinicians begin to change practice patterns.
Bryan Bechtel, Editor-in-Chief
April 2015 | Business Of Retina
SGR: What Is It, Why Is It Important, and What Does It Mean for Ophthalmology?
An Interview with Michael X. Repka, MD
Solutions For a Pair of Puzzling Surgical Coding Issues
A review of two common questions regarding coding for unique situations.
Riva Lee Asbell
April 2015 | Retina Surgery
Pearls for Pediatric Retina Surgery
Audina Berrocal, MD, and Michael Trese, MD
Internal Limiting Membrane: Making the Decision to Peel
The decision should be based on the patient's disease condition.
Chi-Chun Lai, MD
April 2015 | Medical Retina
Noninfectious Uveitis: New Treatment Possibilities with Intravitreal Immunoregulatory Therapy
Quan Dong Nguyen, MD, MSc
April 2015 | Ocular Oncology
Stunning Visualization of Fetal Hyaloid Artery
Sugandha Singh, BA; Murat Hasanreisoglu, MD; Renelle Pointdujour Lim, MD; and Carol L. Shields, MD
April 2015 | Trauma
Laser Pointer Retinal Injures
Injury from laser pointer trauma is a public health problem on the rise.
Gregory D. Lee, MD, and David R. Lally, MD
April 2015 | Special Focus: Fellowship Training
Different Fellowship Structures
The differing structures of fellowship programs create a field of doctors with diverse experience.
Jessica Randolph, MD; Joshua Mali, MD; and Ashleigh Levison, MD
The Value of Mentorship Inside and Outside the OR
Mentorship, which keeps retina alive, occurs in places other than the OR.
Denis Jusufbegovic, MD, and Ahmet Ozkok, MD
April 2015 | Cover Stories
What Is New with Anti-VEGF Therapy for DME
A wealth of evidence supports anti-VEGF therapy in DME.
Dilsher S. Dhoot, MD, and Dante Pieramici, MD
The DME Pipeline
The outlook for new therapies for diabetic macular edema is bright—and it will have to be to meet the rising demand for treatment.
Peter K. Kaiser, MD
The Role of Corticosteroid Implants in DME
Sustained-release platforms offer an alternative solution for patients with inadequate or no response to anti-VEGF therapy while addressing important compliance issues.
Nancy Holekamp, MD
What is the Current Role of Laser Therapy in the Management of DME?
Subthreshold laser may provide a viable adjunct to pharmacologic therapy in selected patients.
Sam E. Mansour, MSc, MD, FRCS(C), FACS
Crowdsourcing for Rapid Fundus Photograph Interpretation
Third-party interpretations of fundus photographs could lighten the burden on retina specialists.
Christopher J. Brady, MD
Switching Therapy in Patients with DME
Three physicians offer their thoughts on when and why they consider changing therapy modalities.
David Eichenbaum, MD; John W. Kitchens, MD; and Andrew A. Moshfeghi, MD, MBA
Ultra-Widefield Imaging: Advancing the Understanding and Management of Diabetic Retinopathy
Routine, rapid visualization of the retinal periphery will facilitate earlier diagnosis, more accurate evaluation, and better treatment outcomes.
Paul E. Tornambe, MD, FACS